Suppr超能文献

相似文献

2
Alcohol-induced IL-1β in the brain is mediated by NLRP3/ASC inflammasome activation that amplifies neuroinflammation.
J Leukoc Biol. 2013 Jul;94(1):171-82. doi: 10.1189/jlb.1212659. Epub 2013 Apr 26.
6
NLRP3 inflammasome blockade reduces liver inflammation and fibrosis in experimental NASH in mice.
J Hepatol. 2017 May;66(5):1037-1046. doi: 10.1016/j.jhep.2017.01.022. Epub 2017 Feb 3.
9
Mechanisms that lead to the regulation of NLRP3 inflammasome expression and activation in human dental pulp fibroblasts.
Mol Immunol. 2015 Aug;66(2):253-62. doi: 10.1016/j.molimm.2015.03.009. Epub 2015 Apr 2.

引用本文的文献

1
NLRP3 Inflammasome Activation in Liver Disorders: From Molecular Pathways to Therapeutic Strategies.
J Inflamm Res. 2025 Jun 24;18:8277-8294. doi: 10.2147/JIR.S532908. eCollection 2025.
5
Dual role of pyroptosis in liver diseases: mechanisms, implications, and therapeutic perspectives.
Front Cell Dev Biol. 2025 Jan 23;13:1522206. doi: 10.3389/fcell.2025.1522206. eCollection 2025.
6
The N-terminal domain of gasdermin D induces liver fibrosis by reprogrammed lipid metabolism.
Animal Model Exp Med. 2025 Jan;8(1):114-125. doi: 10.1002/ame2.12506. Epub 2024 Dec 27.
7
The Role of the AIM2 Gene in Obesity-Related Glucose and Lipid Metabolic Disorders: A Recent Update.
Diabetes Metab Syndr Obes. 2024 Oct 21;17:3903-3916. doi: 10.2147/DMSO.S488978. eCollection 2024.
8
Purinergic signaling in liver disease: calcium signaling and induction of inflammation.
Purinergic Signal. 2025 Feb;21(1):69-81. doi: 10.1007/s11302-024-10044-9. Epub 2024 Sep 25.
9
Inflammasome components as new therapeutic targets in inflammatory disease.
Nat Rev Immunol. 2025 Jan;25(1):22-41. doi: 10.1038/s41577-024-01075-9. Epub 2024 Sep 9.
10
DNA sensors in metabolic and cardiovascular diseases: Molecular mechanisms and therapeutic prospects.
Immunol Rev. 2025 Jan;329(1):e13382. doi: 10.1111/imr.13382. Epub 2024 Aug 19.

本文引用的文献

1
Activation and regulation of the inflammasomes.
Nat Rev Immunol. 2013 Jun;13(6):397-411. doi: 10.1038/nri3452.
2
IL-1 receptor antagonist ameliorates inflammasome-dependent alcoholic steatohepatitis in mice.
J Clin Invest. 2012 Oct;122(10):3476-89. doi: 10.1172/JCI60777. Epub 2012 Sep 4.
3
Inflammasomes in liver diseases.
J Hepatol. 2012 Sep;57(3):642-54. doi: 10.1016/j.jhep.2012.03.035. Epub 2012 May 23.
4
Choline deprivation: an overview of the major hepatic metabolic response pathways.
Scand J Gastroenterol. 2012 Sep;47(8-9):874-86. doi: 10.3109/00365521.2012.685755. Epub 2012 May 10.
5
Caspase-1-mediated regulation of fibrogenesis in diet-induced steatohepatitis.
Lab Invest. 2012 May;92(5):713-23. doi: 10.1038/labinvest.2012.45. Epub 2012 Mar 12.
6
Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity.
Nature. 2012 Feb 1;482(7384):179-85. doi: 10.1038/nature10809.
8
Hepatitis C virus activates interleukin-1β via caspase-1-inflammasome complex.
J Gen Virol. 2012 Feb;93(Pt 2):235-246. doi: 10.1099/vir.0.034033-0. Epub 2011 Oct 12.
9
Inflammasome is a central player in the induction of obesity and insulin resistance.
Proc Natl Acad Sci U S A. 2011 Sep 13;108(37):15324-9. doi: 10.1073/pnas.1100255108. Epub 2011 Aug 29.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验